查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1684325

药物-设备组合产品市场，按产品类型、按应用、按最终用户、按技术、按国家和地区 - 2025 年至 2032 年全球行业分析、市场规模、市场份额和预测

Drug-Device Combination Products Market, By Product Type, By Application, By End-User, By Technology, By Country, and By Region - Global Industry Analysis, Market Size, Market Share & Forecast from 2025-2032
出版日期: | 出版商: AnalystView Market Insights | 英文 383 Pages | 商品交期: 2-3个工作天内

价格
简介目录

报告重点

2024 年药物设备组合产品市场规模价值为 139,489.42 百万美元，2025 年至 2032 年期间的复合年增长率为 8.9%。

药械组合产品市场-市场动态

预计对微创药物输送设备的需求不断增加以及糖尿病等慢性疾病的盛行率不断上升将推动市场的发展。

随着糖尿病、心血管疾病和呼吸系统疾病等疾病的发生率上升，药物-器械组合产品的使用率显着增加，以提高治疗效果、患者依从性和整体医疗保健效果。随着需要长期药物管理的患者数量不断增加，药物-设备组合产品（例如胰岛素帮浦、自动注射器和预充式註射器）的使用正在增加，以提高治疗效果和患者依从性。美国糖尿病协会进行的一项研究涉及 432 个糖尿病中心的 96,547 名第 1 型糖尿病患者。此外，技术的进步以及监管支持和批准的增加可能会为市场扩张带来机会。然而，高昂的製造和开发成本可能会对市场成长构成挑战。

药物-设备组合产品市场-关键见解

根据我们的研究分析师的分析，预测期内（2025-2032 年），全球市场预计年复合成长率约为 8.9%

根据产品类型细分，透皮贴片预计将在 2024 年占据最大市场份额

根据应用细分，心血管是 2024 年领先的应用

根据最终用户细分，医院是 2024 年领先的最终用户

从地区来看，北美是 2024 年的主要收入来源

药物-设备组合产品市场-細項分析：

全球药物设备组合产品市场根据产品类型、应用、最终用户和地区进行细分。

根据产品类型，市场分为五个部分：药物洗脱支架、输液帮浦、吸入器、骨科组合产品、伤口护理组合产品、光动力治疗设备、透皮贴片、抗菌导管等。透皮贴片处于市场成长的最前沿。在透皮给药系统创新的推动下，药物-设备组合产品市场正经历显着扩张。透皮贴片是该领域的重要组成部分，与口服或註射剂相比，它有助于控制药物释放，增强患者依从性，并减轻全身副作用。 FDA 和 EMA 对下一代贴片的监管批准正在促进市场成长。此外，生物相容性和可生物降解的贴片的开发旨在减少皮肤刺激。

根据应用，市场分为四个主要类别：心血管、糖尿病、癌症治疗、呼吸系统疾病和其他。心血管领域引领市场。药械组合产品市场正在经历大幅增长，尤其是在心血管领域，这得益于心臟病发病率的上升以及对复杂、微创治疗方案的需求不断增长。这些产品将药品与医疗器材结合在一起，以改善治疗效果、增强患者依从性并缩短住院时间。

根据最终用户，市场分为两个部分：医院、门诊手术中心和其他。医院部门是该市场的领导部门。药械组合产品市场正在经历快速成长，其中医院对先进、高效、微创治疗方案的需求不断增加，对这一趋势做出了巨大贡献。这些产品将药品与医疗器材结合在一起，从而提高治疗效果、患者依从性和医院内的运作效率。高精度药物管理对于重症监护患者至关重要，因此医院成为这些组合产品的主要最终用户，这些产品对于重症监护、外科手术和慢性病管理至关重要。此外，医院越来越多地采用微创技术，这导致药物洗脱支架和基于导管的药物传输系统的使用增加。

药物设备组合产品市场-地理洞察

北美凭藉其先进的医疗保健基础设施和大量的研发活动引领市场成长。该地区受益于强有力的监管框架和优惠的报销政策，这进一步促进了市场成长。 2022年，美国医疗卫生支出上涨4.1%，达4.5兆美元，人均医疗保健支出1,3,493美元。根据美国医学协会报告，这一成长率与疫情前的数据一致。同时，随着慢性病发生率的上升，中国、日本、印度等国对药械组合产品的需求也日益增长。此外，阿联酋和南非因加大对医疗创新的投资而成为重要的市场。

药物-设备组合产品市场-竞争格局：

药物-设备组合产品市场竞争激烈，主要参与者专注于技术进步、监管批准和策略合作，以加强其市场地位。推动这项竞争的因素包括对先进药物输送系统的需求不断增长、慢性病发病率不断上升以及对微创治疗的偏好日益增加。各公司透过开发能够提高患者便利性和治疗效果的下一代药物-设备组合来展开竞争。由于医疗保健投资的增加，各大公司正在向新兴市场（亚太地区、拉丁美洲和中东）扩张。

最新动态：

2024年5月，诺华宣布已达成协议，收购位于麻萨诸塞州沃特敦的临床前阶段的生技公司Mariana Oncology。该公司专门开发创新放射性配体疗法 (RLT)，旨在解决存在重大未满足医疗需求的癌症。

目录

第 1 章：药物设备组合产品市场概览

  • 研究范围
  • 市场估计年限

第 2 章：执行摘要

  • 市场片段
    • 药物设备组合产品市场片段（依产品类型）
    • 药物设备组合产品市场片段（依应用）
    • 药物设备组合产品市场片段（依最终用户）
    • 药物设备组合产品市场（按国家/地区）摘要
    • 药物设备组合产品市场片段（按地区）
  • 竞争洞察

第 3 章：药物设备组合产品关键市场趋势

  • 药物设备组合产品市场驱动因素
    • 市场驱动因素的影响分析
  • 药物设备组合产品市场限制
    • 市场限制的影响分析
  • 药物设备组合产品市场机会
  • 药械组合产品市场未来趋势

第 4 章：药物器材组合产品产业研究

  • PEST分析
  • 波特五力分析
  • 成长前景规划
  • 规范架构分析

第 5 章：药物设备组合产品市场：地缘政治紧张局势升级的影响

  • 新冠肺炎疫情的影响
  • 俄乌战争的影响
  • 中东衝突的影响

第 6 章：药物器材组合产品市场格局

  • 2024 年药物设备组合产品市占率分析
  • 按主要製造商分類的细分数据
    • 成熟玩家分析
    • 新兴企业分析

第 7 章：药物设备组合产品市场 - 依产品类型

  • 概述
    • 按产品类型分類的细分市场占有率分析
    • 药物洗脱支架
    • 点滴帮浦
    • 吸入器
    • 骨科组合产品
    • 伤口护理组合产品
    • 光动力治疗仪
    • 透皮贴剂
    • 抗菌导管
    • 其他的

第 8 章：药物设备组合产品市场 - 按应用

  • 概述
    • 按应用分類的细分市场占有率分析
    • 心血管
    • 糖尿病
    • 癌症治疗
    • 呼吸系统疾病
    • 其他

第 9 章：药物设备组合产品市场 - 按最终用户

  • 概述
    • 按最终用户分類的细分市场占有率分析
    • 医院
    • 门诊手术中心
    • 其他

第 10 章：药物设备组合产品市场-按地区

  • 介绍
    • 按地区分類的细分市场占有率分析
  • 北美洲
    • 概述
    • 北美药械组合产品主要製造商
    • 北美市场规模及预测（按国家/地区）
    • 北美市场规模及预测（依产品类型）
    • 北美市场规模与预测，按应用划分
    • 北美市场规模及预测（按最终用户）
    • 我们
    • 加拿大
  • 欧洲
    • 概述
    • 欧洲药械组合产品主要製造商
    • 欧洲市场规模及预测（按国家）
    • 欧洲市场规模及预测（依产品类型）
    • 欧洲市场规模和预测，按应用
    • 欧洲市场规模及预测（按最终用户）
    • 德国
    • 英国
    • 法国
    • 义大利
    • 西班牙
    • 荷兰
    • 瑞典
    • 俄罗斯
    • 波兰
    • 欧洲其他地区
  • 亚太地区 (APAC)
    • 概述
    • 亚太地区药物器材组合产品主要製造商
    • 亚太地区市场规模及预测（依国家/地区划分）
    • 亚太地区市场规模及预测（依产品类型）
    • 亚太地区市场规模及预测（按应用划分）
    • 亚太地区市场规模及预测（依最终用户）
    • 中国
    • 印度
    • 日本
    • 韩国
    • 澳洲
    • 印尼
    • 泰国
    • 菲律宾
    • 亚太地区其他地区
  • 拉丁美洲 (LATAM)
    • 概述
    • 拉丁美洲药物器械组合产品主要製造商
    • 拉丁美洲市场规模及预测（按国家/地区）
    • 拉丁美洲市场规模及预测（依产品类型）
    • 拉丁美洲市场规模及预测（按应用划分）
    • 拉丁美洲市场规模及预测（按最终用户）
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥伦比亚
    • 拉丁美洲其他地区
  • 中东和非洲 (MEA)
    • 概述
    • 中东和非洲的药物设备组合产品主要製造商
    • MEA 市场规模及预测（依国家/地区划分）
    • MEA 市场规模及预测（依产品类型）
    • MEA 市场规模及预测（按应用）
    • MEA 市场规模及预测（依最终用户）
    • 沙乌地阿拉伯
    • 阿联酋
    • 以色列
    • 土耳其
    • 阿尔及利亚
    • 埃及
    • MEA 其他地区

第 11 章：主要供应商分析-药物设备组合产品产业

  • 竞争仪錶板
    • Competitive Benchmarking
    • Competitive Positioning
  • 公司简介
    • Abbott Laboratories
    • Medtronic Plc
    • Boston Scientific Corp.
    • Becton
    • Dickinson and Company
    • Novartis AG
    • GlaxoSmithKline plc
    • AbbVie Inc. (Allergan)
    • WL Gore & Associates Inc.
    • Stryker Corporation
    • Terumo Corporation
    • Others

第 12 章：360 度分析师视角

第 13 章：附录

  • 研究方法
  • 参考
  • 缩写
  • 免责声明
  • 联络我们
简介目录
Product Code: ANV4846

REPORT HIGHLIGHT

Drug Device Combination Products Market size was valued at US$ 139,489.42 Million in 2024, expanding at a CAGR of 8.9% from 2025 to 2032.

Drug-Device Combination Products represent innovative therapeutic and diagnostic solutions that integrate a pharmaceutical agent with a medical device into a unified system. These products aim to improve the efficiency of drug delivery and facilitate the controlled administration of medications. In response to the increasing demand from patients for more convenient and accessible treatment alternatives, pharmaceutical companies are progressively investing in sophisticated delivery mechanisms, including prefilled syringes, auto-injectors, and on-body injectors. Concurrently, regulatory frameworks in both the United States and the European Union are undergoing continuous development. In the United States, information about the device component of drug-led combination products is generally submitted through a singular marketing application, following the regulatory pathways for drugs or biologics, such as the Biologics License Application (BLA), New Drug Application (NDA), or Investigational New Drug (IND).

Drug-Device Combination Products Market- Market Dynamics

Increasing demand for minimally invasive drug delivery devices and increasing prevalence of chronic diseases such as diabetes are anticipated to drive the market.

As the prevalence of conditions such as diabetes, cardiovascular diseases, and respiratory disorders rises, there is a notable increase in the utilization of Drug-Device Combination Products to enhance treatment efficacy, patient compliance, and overall healthcare results. With the growing population of patients requiring long-term medication management, the use of Drug-Device Combination Products, such as insulin pumps, auto-injectors, and prefilled syringes, is on the rise to improve treatment effectiveness and patient adherence. A study conducted by the American Diabetes Association included 96,547 patients with type 1 diabetes across 432 diabetes centers. Additionally, advancements in technology, along with increasing regulatory support and approvals, may present opportunities for market expansion. Nevertheless, high manufacturing and development costs could pose challenges to market growth.

Drug-Device Combination Products Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 8.9% over the forecast period (2025-2032)

Based on product type segmentation, Transdermal Patches was predicted to show maximum market share in the year 2024

Based on Application segmentation, Cardiovascular was the leading Application in 2024

Based on End-User segmentation, the hospital was the leading End-User in 2024

Based on region, North America was the leading revenue generator in 2024

Drug-Device Combination Products Market- Segmentation Analysis:

The Global Drug Device Combination Products Market is segmented based on Product Type, Application, End-User, and Region.

The market is categorized into five segments according to product type: Drug Eluting Stents, Infusion Pumps, Inhalers, Orthopedic Combination Products, Wound Care Combination Products, Photodynamic Therapy Devices, Transdermal Patches, Antimicrobial Catheters, and Others. Transdermal Patches are at the forefront of market growth. The Drug-Device Combination Products Market is witnessing significant expansion, propelled by innovations in transdermal drug delivery systems. Transdermal patches, a vital component of this sector, facilitate controlled drug release, enhance patient adherence, and mitigate systemic side effects when compared to oral or injectable options. Regulatory approvals from the FDA and EMA for next-generation patches are contributing to market growth. Additionally, the development of biocompatible and biodegradable patches aims to reduce skin irritation.

The market is classified into four primary categories based on application: Cardiovascular, Diabetes, Cancer Treatment, Respiratory Diseases, and Other. The Cardiovascular segment leads the market. The Drug-Device Combination Products Market is experiencing substantial growth, especially within the cardiovascular segment, driven by the rising incidence of heart diseases and the growing need for sophisticated, minimally invasive treatment options. These products integrate pharmaceuticals with medical devices to improve therapeutic results, enhance patient adherence, and shorten hospital stays.

The market is categorized into two segments based on End-User: Hospitals, Ambulatory Surgical Centers, and Others. The hospital segment is the leading sector within this market. The Drug-Device Combination Products Market is experiencing rapid growth, with hospitals significantly contributing to this trend due to the increasing demand for advanced, efficient, and minimally invasive treatment options. These products combine pharmaceuticals with medical devices, thereby improving therapeutic effectiveness, patient adherence, and operational efficiency within hospital settings. High-precision drug administration is essential for patients in critical care, making hospitals the primary end-users of these combination products, which are vital for critical care, surgical procedures, and the management of chronic diseases. Furthermore, hospitals are increasingly adopting minimally invasive techniques, which has led to a rise in the use of drug-eluting stents and catheter-based drug delivery systems.

Drug Device Combination Products Market- Geographical Insights

North America leads in market growth, attributed to its advanced healthcare infrastructure and significant research and development activities. The region benefits from a robust regulatory framework and advantageous reimbursement policies, which further facilitate market growth. In 2022, health expenditures in the United States rose by 4.1%, reaching USD 4.5 trillion, or USD 13,493 per capita. This growth rate aligns with pre-pandemic figures, as reported by the American Medical Association. Meanwhile, countries such as China, Japan, and India are witnessing a growing demand for drug-device combination products, driven by the rising incidence of chronic diseases. Additionally, the UAE and South Africa represent important markets due to their increased investments in medical innovation.

Drug-Device Combination Products Market- Competitive Landscape:

The Drug-Device Combination Products Market is highly competitive, with key players focusing on technological advancements, regulatory approvals, and strategic collaborations to strengthen their market position. The competition is driven by the rising demand for advanced drug delivery systems, the increasing prevalence of chronic diseases, and the growing preference for minimally invasive treatments. Companies compete by developing next-generation drug-device combinations that enhance patient convenience and therapeutic efficacy. Major companies are expanding into emerging markets (Asia-Pacific, Latin America, and the Middle East) due to increasing healthcare investments.

Recent Developments:

In May 2024, Novartis announced that it had reached an agreement to acquire Mariana Oncology, a biotechnology firm in the preclinical stage located in Watertown, Massachusetts. The company specializes in the development of innovative radio ligand therapies (RLTs) aimed at addressing cancers that present significant unmet medical needs.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL DRUG DEVICE COMBINATION PRODUCTS MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

  • Abbott Laboratories
  • Medtronic Plc
  • Boston Scientific Corp.
  • Becton
  • Dickinson and Company
  • Novartis AG
  • GlaxoSmithKline plc
  • AbbVie Inc. (Allergan)
  • W. L. Gore & Associates Inc.
  • Stryker Corporation
  • Terumo Corporation
  • Others

GLOBAL DRUG DEVICE COMBINATION PRODUCTS MARKET, BY PRODUCT TYPE- MARKET ANALYSIS, 2019 - 2032

  • Drug Eluting Stents
  • Infusion Pumps
  • Inhalers
  • Orthopedic Combination Products
  • Wound Care Combination Products
  • Photodynamic Therapy Devices
  • Transdermal Patches
  • Antimicrobial Catheters
  • Others

GLOBAL DRUG DEVICE COMBINATION PRODUCTS MARKET, BY APPLICATION- MARKET ANALYSIS, 2019 - 2032

  • Cardiovascular
  • Diabetes
  • Cancer Treatment
  • Respiratory Diseases
  • Other

GLOBAL DRUG DEVICE COMBINATION PRODUCTS MARKET, BY END-USER- MARKET ANALYSIS, 2019 - 2032

  • Hospitals
  • Ambulatory Surgical Centers
  • Other

GLOBAL DRUG DEVICE COMBINATION PRODUCTS MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • The Netherlands
  • Sweden
  • Russia
  • Poland
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Australia
  • Indonesia
  • Thailand
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • UAE
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Drug Device Combination Products Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Drug Device Combination Products Market Snippet by Product Type
    • 2.1.2. Drug Device Combination Products Market Snippet by Application
    • 2.1.3. Drug Device Combination Products Market Snippet by End-User
    • 2.1.4. Drug Device Combination Products Market Snippet by Country
    • 2.1.5. Drug Device Combination Products Market Snippet by Region
  • 2.2. Competitive Insights

3. Drug Device Combination Products Key Market Trends

  • 3.1. Drug Device Combination Products Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Drug Device Combination Products Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Drug Device Combination Products Market Opportunities
  • 3.4. Drug Device Combination Products Market Future Trends

4. Drug Device Combination Products Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Drug Device Combination Products Market: Impact of Escalating Geopolitical Tensions

  • 5.1. Impact of COVID-19 Pandemic
  • 5.2. Impact of Russia-Ukraine War
  • 5.3. Impact of Middle East Conflicts

6. Drug Device Combination Products Market Landscape

  • 6.1. Drug Device Combination Products Market Share Analysis, 2024
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Drug Device Combination Products Market - By Product Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Product Type, 2024 & 2032 (%)
    • 7.1.2. Drug Eluting Stents
    • 7.1.3. Infusion Pumps
    • 7.1.4. Inhalers
    • 7.1.5. Orthopedic Combination Products
    • 7.1.6. Wound Care Combination Products
    • 7.1.7. Photodynamic Therapy Devices
    • 7.1.8. Transdermal Patches
    • 7.1.9. Antimicrobial Catheters
    • 7.1.10. Others

8. Drug Device Combination Products Market - By Application

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Application, 2024 & 2032 (%)
    • 8.1.2. Cardiovascular
    • 8.1.3. Diabetes
    • 8.1.4. Cancer Treatment
    • 8.1.5. Respiratory Diseases
    • 8.1.6. Other

9. Drug Device Combination Products Market - By End-User

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By End-User, 2024 & 2032 (%)
    • 9.1.2. Hospitals
    • 9.1.3. Ambulatory Surgical Centers
    • 9.1.4. Other

10. Drug Device Combination Products Market- By Geography

  • 10.1. Introduction
    • 10.1.1. Segment Share Analysis, By Geography, 2024 & 2032 (%)
  • 10.2. North America
    • 10.2.1. Overview
    • 10.2.2. Drug Device Combination Products Key Manufacturers in North America
    • 10.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.2.4. North America Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 10.2.5. North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.2.6. North America Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.2.7. U.S.
      • 10.2.7.1. Overview
      • 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.7.3. U.S. Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.2.7.4. U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.2.7.5. U.S. Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.2.8. Canada
      • 10.2.8.1. Overview
      • 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.8.3. Canada Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.2.8.4. Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.2.8.5. Canada Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 10.3. Europe
    • 10.3.1. Overview
    • 10.3.2. Drug Device Combination Products Key Manufacturers in Europe
    • 10.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.3.4. Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 10.3.5. Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.6. Europe Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.7. Germany
      • 10.3.7.1. Overview
      • 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.7.3. Germany Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.7.4. Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.7.5. Germany Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.8. UK
      • 10.3.8.1. Overview
      • 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.8.3. UK Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.8.4. UK Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.8.5. UK Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.9. France
      • 10.3.9.1. Overview
      • 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.9.3. France Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.9.4. France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.9.5. France Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.10. Italy
      • 10.3.10.1. Overview
      • 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.10.3. Italy Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.10.4. Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.10.5. Italy Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.11. Spain
      • 10.3.11.1. Overview
      • 10.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.11.3. Spain Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.11.4. Spain Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.11.5. Spain Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.12. The Netherlands
      • 10.3.12.1. Overview
      • 10.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.12.3. The Netherlands Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.12.4. The Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.12.5. The Netherlands Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.13. Sweden
      • 10.3.13.1. Overview
      • 10.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.13.3. Sweden Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.13.4. Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.13.5. Sweden Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.14. Russia
      • 10.3.14.1. Overview
      • 10.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.14.3. Russia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.14.4. Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.14.5. Russia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.15. Poland
      • 10.3.15.1. Overview
      • 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.15.3. Poland Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.15.4. Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.15.5. Poland Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.16. Rest of Europe
      • 10.3.16.1. Overview
      • 10.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.16.3. Rest of the Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.16.4. Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.16.5. Rest of the Europe Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 10.4. Asia Pacific (APAC)
    • 10.4.1. Overview
    • 10.4.2. Drug Device Combination Products Key Manufacturers in Asia Pacific
    • 10.4.3. APAC Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.4.4. APAC Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 10.4.5. APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.6. APAC Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.7. China
      • 10.4.7.1. Overview
      • 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.7.3. China Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.7.4. China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.7.5. China Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.8. India
      • 10.4.8.1. Overview
      • 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.8.3. India Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.8.4. India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.8.5. India Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.9. Japan
      • 10.4.9.1. Overview
      • 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.9.3. Japan Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.9.4. Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.9.5. Japan Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.10. South Korea
      • 10.4.10.1. Overview
      • 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.10.3. South Korea Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.10.4. South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.10.5. South Korea Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.11. Australia
      • 10.4.11.1. Overview
      • 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.11.3. Australia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.11.4. Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.11.5. Australia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.12. Indonesia
      • 10.4.12.1. Overview
      • 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.12.3. Indonesia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.12.4. Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.12.5. Indonesia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.13. Thailand
      • 10.4.13.1. Overview
      • 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.13.3. Thailand Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.13.4. Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.13.5. Thailand Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.14. Philippines
      • 10.4.14.1. Overview
      • 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.14.3. Philippines Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.14.4. Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.14.5. Philippines Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.15. Rest of APAC
      • 10.4.15.1. Overview
      • 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.15.3. Rest of APAC Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.15.4. Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.15.5. Rest of APAC Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 10.5. Latin America (LATAM)
    • 10.5.1. Overview
    • 10.5.2. Drug Device Combination Products Key Manufacturers in Latin America
    • 10.5.3. LATAM Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.5.4. LATAM Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 10.5.5. LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.5.6. LATAM Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.5.7. Brazil
      • 10.5.7.1. Overview
      • 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.7.3. Brazil Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.5.7.4. Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.7.5. Brazil Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.5.8. Mexico
      • 10.5.8.1. Overview
      • 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.8.3. Mexico Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.5.8.4. Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.8.5. Mexico Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.5.9. Argentina
      • 10.5.9.1. Overview
      • 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.9.3. Argentina Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.5.9.4. Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.9.5. Argentina Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.5.10. Colombia
      • 10.5.10.1. Overview
      • 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.10.3. Colombia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.5.10.4. Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.10.5. Colombia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.5.11. Rest of LATAM
      • 10.5.11.1. Overview
      • 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.11.3. Rest of LATAM Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.5.11.4. Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.11.5. Rest of LATAM Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 10.6. Middle East and Africa (MEA)
    • 10.6.1. Overview
    • 10.6.2. Drug Device Combination Products Key Manufacturers in Middle East and Africa
    • 10.6.3. MEA Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.6.4. MEA Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 10.6.5. MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.6.6. MEA Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.6.7. Saudi Arabia
      • 10.6.7.1. Overview
      • 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.7.3. Saudi Arabia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.7.4. Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.7.5. Saudi Arabia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.6.8. UAE
      • 10.6.8.1. Overview
      • 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.8.3. UAE Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.8.4. UAE Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.8.5. UAE Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.6.9. Israel
      • 10.6.9.1. Overview
      • 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.9.3. Israel Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.9.4. Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.9.5. Israel Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.6.10. Turkey
      • 10.6.10.1. Overview
      • 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.10.3. Turkey Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.10.4. Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.10.5. Turkey Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.6.11. Algeria
      • 10.6.11.1. Overview
      • 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.11.3. Algeria Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.11.4. Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.11.5. Algeria Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.6.12. Egypt
      • 10.6.12.1. Overview
      • 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.12.3. Egypt Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.12.4. Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.12.5. Egypt Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.6.13. Rest of MEA
      • 10.6.13.1. Overview
      • 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.13.3. Rest of MEA Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.13.4. Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.13.5. Rest of MEA Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)

11. Key Vendor Analysis- Drug Device Combination Products Industry

  • 11.1. Competitive Dashboard
    • 11.1.1. Competitive Benchmarking
    • 11.1.2. Competitive Positioning
  • 11.2. Company Profiles
    • 11.2.1. Abbott Laboratories
    • 11.2.2. Medtronic Plc
    • 11.2.3. Boston Scientific Corp.
    • 11.2.4. Becton
    • 11.2.5. Dickinson and Company
    • 11.2.6. Novartis AG
    • 11.2.7. GlaxoSmithKline plc
    • 11.2.8. AbbVie Inc. (Allergan)
    • 11.2.9. W. L. Gore & Associates Inc.
    • 11.2.10. Stryker Corporation
    • 11.2.11. Terumo Corporation
    • 11.2.12. Others

12. 360 Degree AnalystView

13. Appendix

  • 13.1. Research Methodology
  • 13.2. References
  • 13.3. Abbreviations
  • 13.4. Disclaimer
  • 13.5. Contact Us